Campbell & CO Investment Adviser LLC Revance Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$11.47 - $25.07 $975,798 - $2.13 Million	85,074 Added 537.32%	100,907 $1.16 Million
Q2 2023 Aug 11, 2023	BUY	$24.7 - $37.61 $391,075 - $595,479	15,833 New	15,833 $400,000
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $520,104 - $870,437	28,390 New	28,390 $524,000
Q3 2021 Nov 10, 2021	SELL	$25.78 - $33.21 $324,828 - $418,446	-12,600 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$26.8 - $31.84 $337,680 - $401,184	12,600 New	12,600 $373,000
Q2 2019 Jul 10, 2019	SELL	$10.67 - $15.49 $114,979 - $166,920	-10,776 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$15.4 - $20.39 $165,950 - $219,722	10,776 New	10,776 $170,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.